MDS and MPN
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Current and Future Treatment Landscape of Myelofibrosis
FEATURING
Rami Komrokji
- 110 views
- October 8, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Eosinophilia: How To Manage the Orphan MPN
FEATURING
Hanan Hamed
- 5 views
- September 27, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Secondary Solid Development Ph- MPNs: Frequency, Characteristics and Risk Factors
FEATURING
Elif Aksoy
- 4 views
- September 27, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Biochemical Properties of Red Blood Cells in PV
FEATURING
Weronika Lebowa
- 2 views
- September 25, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Myelofibrosis Case Discussion: Patient With Splanchnic Venous Thrombosis
FEATURING
Weronika Lebowa
- 10 views
- September 25, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
MDS: What's Current in Classification and Risk Stratification
FEATURING
Rami Komrokji
- 22 views
- September 25, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
A Case of Thalassemia Minor Coexisting with Chronic Myeloproliferative Disorders
FEATURING
Emir Buyukasik
- 9 views
- September 16, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Retrospective Analysis of Primary MF Patients in Azerbaijan
FEATURING
Elmir Guluyev
- 10 views
- September 16, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Clinical Impact of CALR Mutation in Patients With Essential Thrombocythemia
FEATURING
Elif Aksoy
- 10 views
- September 16, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Current Approaches to Treating Low-Risk MDS
FEATURING
Guillermo Garcia-Manero
- 35 views
- September 16, 2024
- 1
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Current Approaches in PV: Managing Symptoms and Disease
FEATURING
Tayfur Toptas
- 17 views
- September 12, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Current Treatment of Polycythemia Vera
FEATURING
Emre Eşkazan
- 84 views
- August 13, 2024